Dan Goldstein - 01 Jun 2021 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Role
VP, Corporate Controller
Signature
/s/ Thomas V. Powers, attorney-in-fact for Mr. Goldstein
Issuer symbol
HAE
Transactions as of
01 Jun 2021
Transactions value $
$0
Form type
4
Filing time
03 Jun 2021, 16:42:47
Previous filing
20 May 2021
Next filing
09 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HAE Common Stock Award +1.75K +72.41% 4.17K 01 Jun 2021 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 50% beginning on the first anniversary of the date of grant.
F2 Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
F3 This number includes unvested RSUs previously reported.